Tag: samarium
SIGN UP FOR OUR NEWS LETTER


Quick Search

Reset

After Androgen Deprivation

Wed 31 Aug 2011

 Introduction Androgen Deprivation (ADT) can be an effective treatment for controlling prostate cancer for many years in most men. When ADT is no longer effective, you may be told that your cancer is “androgen-independent”, “hormone-resistant”, “hormone-refractory” or “castrate-resistant”. The terms all have similar meaning. For consistency, we will refer to CRPC. The nadir PSA isRead More ›

Bone -Targeted Therapy for Advanced Prostate Cancer

Sun 31 May 2009

Oliver Sartor, MD Tulane University, New Orleans, LA Edited from PCRI Insights May, 2009 v 12.2 Editor’s Note: Dr. Sartor provided this updated version of a paper he presented at the ASCO Genitourinary Cancers Symposium 2009 From several perspectives, bone disease is of particular interest for those treating patients with advanced prostate cancer. First, androgenRead More ›

Newer Concepts in the Treatment of Hormone-Refractory Prostate Cancer with Bone Metastases: Combinations of Bone-Seeking Radiopharmaceuticals and Chemotherapy

Sun 1 May 2005

PCRI Insights May 2005 vol. 8, no. 2 By Oliver Sartor, MD Chief, Hematology-Oncology Section; Director, Stanley S. Scott Cancer Center, LSU Health Sciences Center, New Orleans, LA PAIN FROM BONE METASTASIS IS ONE OF THE MOST DIFFICULT CLINICAL PROBLEMS IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER (HRPC). Radiographic evidence of distant metastatic spread to boneRead More ›